OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clofazimine: A journey of a drug
Jiabin Xu, Alexey Koval, Vladimir L. Katanaev
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115539-115539
Open Access | Times Cited: 10

Showing 10 citing articles:

Historical Examination of Tuberculosis; From Ancient Affliction to Modern Challenges
Seyyed Mohammad Amin Mousavi-Sagharchi, Atousa Ghorbani, Maryam Meskini, et al.
Journal of Infection and Public Health (2025) Vol. 18, Iss. 3, pp. 102649-102649
Open Access

Synthesis and characterization of magnetic molecularly imprinted polymers for the rapid and selective determination of clofazimine in blood plasma samples
Nur Masyithah Zamruddin, Herman Herman, Saliza Asman, et al.
Heliyon (2024) Vol. 10, Iss. 13, pp. e33396-e33396
Open Access | Times Cited: 1

Revolutionizing cancer immunotherapy: The dual role of clofazimine in enhancing efficacy and reducing toxicity
Yiran Zhu, Yong Lu
Clinical and Translational Medicine (2024) Vol. 14, Iss. 7
Open Access | Times Cited: 1

Preparation and in vitro characterization of clofazimine-loaded albumin nanocomposite microparticles for inhalation therapy
Mingyue Gao, Tatsuaki Tagami, Koki Ogawa, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 93, pp. 105364-105364
Closed Access

Having the cake and eating it? Clofazimine boosts immunotherapy while limiting side effects
Lukas Kraehenbuehl, Jedd D. Wolchok, Taha Merghoub, et al.
Cancer Cell (2024) Vol. 42, Iss. 5, pp. 738-741
Closed Access

Mitigating treatment failure of pulmonary pre-extensively drug-resistant tuberculosis: The role of new and repurposed drugs
Yi-Wen Huang, Ming-Chih Yu, Chih‐Bin Lin, et al.
Journal of Microbiology Immunology and Infection (2024) Vol. 57, Iss. 4, pp. 617-628
Open Access

Changes in skin discoloration according to clofazimine dosage in nontuberculous mycobacterial pulmonary disease
Yu Kurahara, Yuya Tanaka, Takehiko Kobayashi, et al.
Journal of Infection and Chemotherapy (2024) Vol. 31, Iss. 1, pp. 102441-102441
Closed Access

Modern approaches to the synthesis of phenazine derivatives (microreview)
Vadim V. Nadtochiy, Igor L. Nikonov, Grigory V. Zyryanov
Chemistry of Heterocyclic Compounds (2024) Vol. 60, Iss. 5-6, pp. 233-235
Closed Access

Clofazimine inhibits small-cell lung cancer progression by modulating the kynurenine/aryl hydrocarbon receptor axis
Gunjan Sharma, K. M. Abdullah, Faizan Abul Qais, et al.
International Journal of Biological Macromolecules (2024) Vol. 282, pp. 136921-136921
Closed Access

Continuous Flow Enabled Synthesis of Multiresistant Drug Clofazimine
Rajat Pandey, Faith M. Akwi, Paul Watts
Organic Process Research & Development (2024) Vol. 28, Iss. 11, pp. 4163-4172
Open Access

Page 1

Scroll to top